GLP-1 research
Referenced in GLP-1, GIP, and glucagon research.
Research →Available
Verification
DocumentedHosted on verify.janoshik.com · Retatrutide 10mg
Price
£125
Questions?
WhatsApp AXIOM →Reading
The most useful adjacent reading is the Tirzepatide comparison set and broader GLP-1 research collection.
GLP-1 and metabolic research references.
categoryRetatrutide UK ResearchRetatrutide UK research reference with catalogue records, GLP-1 comparisons, and available quality details.
categoryGLP-1 Research CompoundsGLP-1 research catalogue for Tirzepatide, Retatrutide, comparisons, and available quality records.
categoryResearch Peptides UKAXIOM UK research catalogue. Peptide references and available certificates.
comparisonTirzepatide vs RetatrutideReceptor profile and research framing for two incretin compounds.
comparisonRetatrutide vs SemaglutideRetatrutide against a familiar GLP-1 reference point.
comparisonCagrilintide vs RetatrutideAmylin research adjacent to incretin and glucagon literature.
peptideRetatrutide (LY3437943)Triple GLP-1/GIP/Glucagon Agonist · Weight Loss & Diabetes
Product record
Usually discussed through GLP-1, GIP, and glucagon receptor research.
Best compared with Tirzepatide when the research question is receptor breadth, not ranking or preference.
Store sealed and dry, away from heat and light. Follow laboratory SOPs and certificate notes where supplied.
Analytical records
Certificates from Janoshik Analytical.
Ref J-122594 · 9 Mar 2026
Ref J-101807 · 16 Jan 2026
Ref J-87897 · 30 Nov 2025
Lyophilised powder
Research catalogue
Questions
Retatrutide is commonly discussed through GLP-1, GIP, and glucagon receptors. Tirzepatide is usually discussed through GIP and GLP-1.
No. AXIOM catalogue products are supplied for laboratory research use only.
Documentation is shown by strength. Open the certificate archive on this page to verify the current record.
Retatrutide is listed in 10mg, 30mg, and 50mg.
Selected strengths link to an independent Janoshik COA. Open the certificate archive on this page.
Retatrutide is commonly referenced through GLP-1, GIP, and glucagon receptor research, whereas Semaglutide is usually discussed as a GLP-1 receptor agonist. AXIOM presents this for research context only, not as a comparison of effect or preference.
LY3437943 is the development designation commonly associated with Retatrutide in the research literature; both refer to the same compound.
Store sealed and dry, away from heat and light, following laboratory SOPs. UK dispatch.
First order with them. Arrived quickly, packaged properly, and customer service was easy to deal with.
Shipping was fast. Outer packaging discreet — inside was tidy and well presented.
Had a quick question before ordering. Sorted straight away, no runaround.
Everything matched what I ordered. Professional overall.